Expression profiling to predict the clinical behaviour of ovarian cancer fails independent evaluation

BMC Cancer

Volumn 8, Issue , 2008, Pages

  Gevaert, Olivier ^a   De Smet, Frank ^a,b   Van Gorp, Toon ^a   Pochet, Nathalie ^a,c,d   Engelen, Kristof ^a   Amant, Frederic ^a   De Moor, Bart ^a   Timmerman, Dirk ^a   Vergote, Ignace ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b National Alliance of Christian Sickness Funds   (Belgium)

^c BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^d HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLATINUM COMPLEX; ANTINEOPLASTIC AGENT; PLATINUM DERIVATIVE;

ADULT; ADVANCED CANCER; ARTICLE; CANCER CLASSIFICATION; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DRUG RESPONSE; FEMALE; GENE EXPRESSION PROFILING; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MICROARRAY ANALYSIS; OUTCOME ASSESSMENT; OVARY CANCER; PILOT STUDY; PREDICTION; PRINCIPAL COMPONENT ANALYSIS; REGRESSION ANALYSIS; SUPPORT VECTOR MACHINE; ALGORITHM; BIOLOGICAL MODEL; COMPARATIVE STUDY; DISEASE COURSE; DNA MICROARRAY; DRUG RESISTANCE; EVALUATION; GENETICS; MIDDLE AGED; OVARY TUMOR; PATHOLOGY; PROGNOSIS;

ALGORITHMS; ANTINEOPLASTIC AGENTS; DISEASE PROGRESSION; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MIDDLE AGED; MODELS, BIOLOGICAL; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OVARIAN NEOPLASMS; PLATINUM COMPOUNDS; PRINCIPAL COMPONENT ANALYSIS; PROGNOSIS;

EID: 40349111098     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-8-18     Document Type: Article

References (23)

1. Jemal A Siegel R Ward E Murray T Xu J Thun MJ Cancer statistics, 2007 CA Cancer J Clin 2007, 57:43-66. 17237035
2. De Smet F Pochet NL Engelen K Van Gorp T Van Hummelen P Marchal K Amant F Timmerman D De Moor BL Vergote IB Predicting the clinical behavior of ovarian cancer from gene expression profiles Int J Gynecol Cancer 2006, 16(Suppl 1):147-151. 10.1111/j.1525-1438.2006.00321.x 16515583
3. Markman M Rothman R Hakes T Reichman B Hoskins W Rubin S Jones W Almadrones L Lewis JL Jr. Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin J Clin Oncol 1991, 9:389-393. 1999708
4. Puskas LG Zvara A Hackler L Jr. Van Hummelen P RNA amplification results in reproducible microarray data with slight ratio bias Biotechniques 2002, 32:1330-4, 1336, 1338, 1340. 12074164
5. Parkinson H Sarkans U Shojatalab M Abeygunawardena N Contrino S Coulson R Farne A Lara GG Holloway E Kapushesky M Lilja P Mukherjee G Oezcimen A Rayner T Rocca-Serra P Sharma A Sansone S Brazma A ArrayExpress - a public repository for microarray gene expression data at the EBI Nucleic Acids Res 2005, 33:D553-D555. 15608260 15608260 540010 10.1093/nar/gki056
6. ArrayExpress 2008 http://www.ebi.ac.uk/arrayexpress
7. LS-SVMlab 2008 http://www.esat.kuleuven.be/sista/lssvmlab/
8. Pochet N De Smet F Suykens J De Moor B Systematic benchmarking of microarray data classification: Assessing the role of non-linearity and dimensionality reduction Bioinformatics 2004 20 3185 3195 10.1093/ bioinformatics/bth383 15231531
9. Helleman J Jansen MP Span PN van Staveren IL Massuger LF Meijer-van Gelder ME Sweep FC Ewing PC van der Burg ME Stoter G Nooter K Berns EM Molecular profiling of platinum resistant ovarian cancer Int J Cancer 2006, 118:1963-1971. 10.1002/ijc.21599 16287073
10. Hartmann LC Lu KH Linette GP Cliby WA Kalli KR Gershenson D Bast RC Stec J Iartchouk N Smith DI Ross JS Hoersch S Shridhar V Lillie J Kaufmann SH Clark EA Damokosh AI Gene expression profiles predict early relapse in ovarian cancer after platinum-paclitaxel chemotherapy Clin Cancer Res 2005, 11:2149-2155. 10.1158/1078-0432.CCR-04-1673 15788660
11. Roberts D Schick J Conway S Biade S Laub PB Stevenson JP Hamilton TC O'Dwyer PJ Johnson SW Identification of genes associated with platinum drug sensitivity and resistance in human ovarian cancer cells Br J Cancer 2005, 92:1149-1158. 10.1038/sj.bjc.6602447 15726096
12. Spentzos D Levine DA Ramoni MF Joseph M Gu X Boyd J Libermann TA Cannistra SA Gene expression signature with independent prognostic significance in epithelial ovarian cancer J Clin Oncol 2004, 22:4700-4710. 10.1200/JCO.2004.04.070 15505275
13. Berchuck A Iversen ES Lancaster JM Pittman J Luo J Lee P Murphy S Dressman HK Febbo PG West M Nevins JR Marks JR Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers Clin Cancer Res 2005, 11:3686-3696. 10.1158/ 1078-0432.CCR-04-2398 15897565
14. Lancaster JM Dressman HK Whitaker RS Havrilesky L Gray J Marks JR Nevins JR Berchuck A Gene expression patterns that characterize advanced stage serous ovarian cancers J Soc Gynecol Investig 2004, 11:51-59. 10.1016/ j.jsgi.2003.07.004 14706684
15. Schwartz DR Kardia SL Shedden KA Kuick R Michailidis G Taylor JM Misek DE Wu R Zhai Y Darrah DM Reed H Ellenson LH Giordano TJ Fearon ER Hanash SM Cho KR Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas Cancer Res 2002, 62:4722-4729. 12183431
16. Zhu Y Wu R Sangha N Yoo C Cho KR Shedden KA Katabuchi H Lubman DM Classifications of ovarian cancer tissues by proteomic patterns Proteomics 2006, 6:5846-5856. 10.1002/pmic.200600165 17068758
17. Lu KH Patterson AP Wang L Marquez RT Atkinson EN Baggerly KA Ramoth LR Rosen DG Liu J Hellstrom I Smith D Hartmann L Fishman D Berchuck A Schmandt R Whitaker R Gershenson DM Mills GB Bast RC Jr. Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis Clin Cancer Res 2004, 10:3291-3300. 10.1158/1078-0432.CCR-03-0409 15161682
18. Hibbs K Skubitz KM Pambuccian SE Casey RC Burleson KM Oegema TR Jr. Thiele JJ Grindle SM Bliss RL Skubitz AP Differential gene expression in ovarian carcinoma: Identification of potential biomarkers Am J Pathol 2004, 165:397-414. 1618570 15277215
19. Ouellet V Provencher DM Maugard CM Le Page C Ren F Lussier C Novak J Ge B Hudson TJ Tonin PN Mes-Masson AM Discrimination between serous low malignant potential and invasive epithelial ovarian tumors using molecular profiling Oncogene 2005, 24:4672-4687. 10.1038/sj.onc.1208214 15940270
20. Lancaster JM Dressman HK Clarke JP Sayer RA Martino MA Cragun JM Henriott AH Gray J Sutphen R Elahi A Whitaker RS West M Marks JR Nevins JR Berchuck A Identification of genes associated with ovarian cancer metastasis using microarray expression analysis Int J Gynecol Cancer 2006, 16:1733-1745. 10.1111/j.1525-1438.2006.00660.x 17009964
21. Spentzos D Levine DA Kolia S Otu H Boyd J Libermann TA Cannistra SA Unique gene expression profile based on pathologic response in epithelial ovarian cancer J Clin Oncol 2005, 23:7911-7918. 10.1200/ JCO.2005.02.9363 16204010
22. De Smet F Pochet NL De Moor BL Van Gorp T Timmerman D Vergote IB Hartmann LC Damokosh AI Hoersch S Independent test set performance in the prediction of early relapse in ovarian cancer with gene expression profiles Clin Cancer Res 2005, 11:7958-7959. 10.1158/ 1078-0432.CCR-05-1216 16278422
23. Dupuy A Simon RM Critical review of published microarray studies for cancer outcome and guidelines on statistical analysis and reporting J Natl Cancer Inst 2007, 99:147-157. 10.1093/jnci/djk018 17227998